作者
Christoph Lange, Ibrahim Abubakar, Jan-Willem C Alffenaar, Graham Bothamley, Jose A Caminero, Anna Cristina C Carvalho, Kwok-Chiu Chang, Luigi Codecasa, Ana Correia, Valeriu Crudu, Peter Davies, Martin Dedicoat, Francis Drobniewski, Raquel Duarte, Cordula Ehlers, Connie Erkens, Delia Goletti, Gunar Günther, Elmira Ibraim, Beate Kampmann, Liga Kuksa, Wiel De Lange, Frank Van Leth, Jan Van Lunzen, Alberto Matteelli, Dick Menzies, Ignacio Monedero, Elvira Richter, Sabine Rüsch-Gerdes, Andreas Sandgren, Anna Scardigli, Alena Skrahina, Enrico Tortoli, Grigory Volchenkov, Dirk Wagner, Marieke J Van Der Werf, Bhanu Williams, Wing-Wai Yew, Jean-Pierre Zellweger, Daniela Maria Cirillo
发表日期
2014/7/1
来源
European Respiratory Journal
卷号
44
期号
1
页码范围
23-63
出版商
European Respiratory Society
简介
The emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) substantially challenges TB control, especially in the European Region of the World Health Organization, where the highest prevalence of MDR/XDR cases is reported. The current management of patients with MDR/XDR-TB is extremely complex for medical, social and public health systems. The treatment with currently available anti-TB therapies to achieve relapse-free cure is long and undermined by a high frequency of adverse drug events, suboptimal treatment adherence, high costs and low treatment success rates. Availability of optimal management for patients with MDR/XDR-TB is limited even in the European Region. In the absence of a preventive vaccine, more effective diagnostic tools and novel therapeutic interventions the control of MDR/XDR-TB will be extremely difficult. Despite recent scientific …
学术搜索中的文章
C Lange, I Abubakar, JWC Alffenaar, G Bothamley… - 2014